These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32787565)

  • 1. Effect of different cloning strategies in pET-28a on solubility and functionality of a staphylococcal phage endolysin.
    Tham HY; Song AA; Yusoff K; Tan GH
    Biotechniques; 2020 Sep; 69(3):161-170. PubMed ID: 32787565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
    Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
    Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-site mutations of phage Bp7 endolysin improves its activities against target bacteria.
    Zhang C; Wang Y; Sun H; Ren H
    Virol Sin; 2015 Oct; 30(5):386-95. PubMed ID: 26490045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a Thermostable Endolysin of the
    Golosova NN; Khlusevich YA; Morozova VV; Matveev AL; Kozlova YN; Tikunov AY; Panina EA; Tikunova NV
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Advanced Chimeric Endolysin to Control Multidrug-Resistant
    Lee C; Kim J; Son B; Ryu S
    ACS Infect Dis; 2021 Aug; 7(8):2081-2092. PubMed ID: 34047546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria.
    Abdurahman MA; Durukan İ; Dinçer T; Pektaş S; Karataş E; Kiliç AO
    Protein J; 2023 Oct; 42(5):596-606. PubMed ID: 37634214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
    Basit A; Qadir S; Qureshi S; Rehman SU
    Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms.
    Ning H; Lin H; Wang J; He X; Lv X; Ju L
    Enzyme Microb Technol; 2021 Aug; 148():109809. PubMed ID: 34116743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Strategy to Identify Endolysins with Lytic Activity against Methicillin-Resistant
    Kim H; Seo J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
    Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
    Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chandran C; Tham HY; Abdul Rahim R; Lim SHE; Yusoff K; Song AA
    PeerJ; 2022; 10():e12648. PubMed ID: 35251775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1.
    Fan J; Zeng Z; Mai K; Yang Y; Feng J; Bai Y; Sun B; Xie Q; Tong Y; Ma J
    Vet Microbiol; 2016 Aug; 191():65-71. PubMed ID: 27374909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci.
    Gu J; Lu R; Liu X; Han W; Lei L; Gao Y; Zhao H; Li Y; Diao Y
    Curr Microbiol; 2011 Dec; 63(6):538-42. PubMed ID: 21947237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.
    Singh PK; Donovan DM; Kumar A
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4621-9. PubMed ID: 24890598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering Endolysins against Methicillin-Resistant
    Yoda T; Matsuhashi A; Matsushita A; Shibagaki S; Sasakura Y; Aoki K; Hosokawa M; Tsuda S
    ACS Infect Dis; 2024 Aug; 10(8):2679-2689. PubMed ID: 38906534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus.
    Kaspar U; de Haro Sautto JA; Molinaro S; Peters G; Idelevich EA; Becker K
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of factors influencing expression and extraction of recombinant bacteriophage endolysins in Escherichia coli.
    Balaban CL; Suárez CA; Boncompain CA; Peressutti-Bacci N; Ceccarelli EA; Morbidoni HR
    Microb Cell Fact; 2022 Mar; 21(1):40. PubMed ID: 35292023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis.
    Knaack D; Idelevich EA; Schleimer N; Molinaro S; Kriegeskorte A; Peters G; Becker K
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):362-368. PubMed ID: 30554844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.